Incidence of class A extended-spectrum β-lactamases in Champagne-Ardenne (France): A 1 year prospective study

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 5, 2007, Pages 956-964

  Brasme, L ^a   Nordmann, P ^b   Fidel, F ^a   Lartigue, M F ^b   Bajolet, O ^a   Poirel, L ^b   Forte, D ^a   Vernet Garnier, V ^a   Madoux, J ^a   Reveil, J C ^c   Alba Sauviat, C ^d   Baudinat, I ^e   Bineau, P ^f   Bouquigny Saison, C ^g   Eloy, C ^h   Lafaurie, C ⁱ   Simeon D ^j   Verquin, J P ^k   Noel F ^l   Strady, C ^a   De Champs, C ^a   more..

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b BICÊTRE HOSPITAL   (France)

^c Centre Hospitalier Manchester   (France)

^d Centre Hospitalier de Chaumont   (France)

^e Laboratoire de Biologie Médicale Centre Hospitalier de Châlons en Champagne   (France)

^f Hospital of Saint Dizier   (France)

^g Centre Hospitalier de Soissons   (France)

^h CENTRE HOSPITALIER DE TROYES   (France)

ⁱ Centre Hospitalier Auban Moet   (France)

^j Centre Hospitalier de Langres   (France)

^k Laboratoire Gillard   (France)

^l Laboratoire Leulier   (France)

more..

Author keywords

Acinetobacter baumannii; Enterobacteriaceae; ESBLs; Insertion sequences; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIAL DNA; BETA LACTAMASE; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 15; BETA LACTAMASE CTX M 16; BETA LACTAMASE CTX M 2; BETA LACTAMASE CTX M 61; BETA LACTAMASE CTX M 9; BETA LACTAMASE SHV; BETA LACTAMASE SHV 2A; BETA LACTAMASE TEM 1; BETA LACTAMASE VEB 1; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; KANAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATION; CONTROLLED STUDY; DNA FLANKING REGION; DOWNSTREAM PROCESSING; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE; ENZYME ANALYSIS; ESCHERICHIA COLI; FRANCE; GENE IDENTIFICATION; GENE SEQUENCE; INTEGRON; NONHUMAN; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PSEUDOMONAS AERUGINOSA; SAMPLING; SPECIES DIFFERENCE;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; FRANCE; HUMANS; POPULATION SURVEILLANCE; PSEUDOMONAS AERUGINOSA; TIME FACTORS;

EID: 35449002948     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm319     Document Type: Article

References (35)

1. Sirot D, Sirot J, Labia R et al. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: Identification of CTX-1, a novel β-lactamase. J Antimicrob Chemother 1987; 20: 323-34.
2. De Champs C, Sirot D, Chanal C et al. Concomitant dissemination of three extended-spectrum β-lactamases among different Enterobacteriaceae isolated in a French hospital. J Antimicrob Chemother 1991; 27 441-57.
3. Bonnet R, Dutour C, Sampaio JLM et al. Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240→Gly. Antimicrob Agents Chemother 2001; 45: 2269-75.
4. Cao V, Lambert T, Nhu DQ et al. Distribution of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob Agents Chemother 2002; 46: 3739-43.
5. PER-1-carrying plasmid pSTI1 encodes an extended-spectrum aminoglycoside 6′-N-acetyltransferase of type Ib. Antimicrob Agents Chemother 2003; 47: 697-703.
6. De Champs C, Poirel L, Bonnet R et al. Prospective survey of β-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolated in a French hospital in 2000. Antimicrob Agents Chemother 2002; 46: 3031-4.
7. De Champs C, Sirot D, Chanal C et al. A 1998 survey of extended-spectrum β-lactamases in Enterobacteriaceae in France. Antimicrob Agents Chemother 2000; 44: 3177-9.
8. Gniadkowski M, Schneider I, Palucha A et al. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing β-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob Agents Chemother 1998; 42: 827-32.
9. Vahaboglu H, Öztürk R, Aygün G et al. Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicentre study. Antimicrob Agents Chemoter 1997; 41: 2265-9.
10. Girlich D, Poirel L, Leelaporn A et al. Molecular epidemiology of the integron-located VEB-1 extended-spectrum β-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J Clin Microbiol 2001; 39: 175-82.
11. De Champs C, Chanal C, Sirot D et al. Frequency and diversity of class A extended-spectrum β-lactamases in hospitals of the Auvergne, France: A 2 year prospective study. J Antimicrob Chemother 2004; 54: 634-9.
12. Valverde A, Coque TM, Sanchez-Moreno MP et al. Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004; 42: 4769-75.
13. Saladin M, Cao VT, Lambert T et al. Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 2002; 209: 161-8.
14. CTX-M β-lactamase gene. Antimicrob Agents Chemother 2003; 47: 2938-45.
15. CTX-M β-lactamase gene. Antimicrob Agents Chemother 2005; 49: 447-50.
16. Toleman MA, Bennett PM, Walsh TR. Common regions e.g. orf513 and antibiotic resistance: IS91-like elements evolving complex class 1 integrons. J Antimicrob Chemother 2006; 58: 1-6.
17. Toleman MA, Bennett PM, Walsh TR. ISCR elements: Novel gene-capturing systems of the 21st century? Microbiol Mol Biol Rev 2006; 70: 296-316.
18. Sirot J. Detection of extended-spectrum plasmid-mediated β-lactamases by disc diffusion. Clin Microbiol Infect 1996; 2 Suppl 1: 35-9.
19. Mabilat C, Goussard S, Sougakoff W et al. Direct sequencing of the amplified structural gene and promoter for the extended-broad-spectrum β-lactamase TEM-9 (RHH-1) of Klebsiella pneumoniae. Plasmid 1990; 23: 27-34.
20. Dutour C, Bonnet R, Marchandin H et al. CTX-M-1, CTX-M-3, and CTX-M-14- β-lactamases from Enterobacteriaceae isolated in France. Antimicrob Agents Chemother 2002; 46: 534-7.
21. Chanawong A, M'Zali FH, Heritage J et al. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother 2002; 46: 630-7.
22. Naas T, Poirel L, Karim A et al. Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum β-lactamase VEB-1 in Pseudomonas aeruginosa. FEMS Microbiol Lett 1999; 176: 411-9.
23. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-7.
24. Karim A, Poirel L, Nagarajan S et al. Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett 2001; 201: 237-41.
25. CTX-M genes. FEMS Microbiol Lett 2004; 234: 201-7.
26. Hernández JR, Martínez-Martínez L, Cantón R et al. Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. Antimicrob Agents Chemother 2005; 49: 2122-5.
27. Naas T, Coignard B, Carbonne A et al. VEB-1 extended-spectrum β-lactamase-producing Acinetobacter baumannii, France. Emerg Infect Dis 2006; 12: 1214-22.
28. Lartigue MF, Fortineau N, Nordmann P. Spread of novel expanded-spectrum β-lactamases in Enterobacteriaceae in a university hospital in the Paris area, France. Clin Microbiol Infect 2005; 11: 588-91.
29. Lavigne JP, Bouziges N, Chanal C et al. Molecular epidemiology of Enterobacteriaceae isolates producing extended-spectrum β-lactamases in a French hospital. J Clin Microbiol 2004; 42: 3805-8.
30. Bonnet R, De Champs C, Sirot D et al. Diversity of TEM mutants in Proteus mirabilis. Antimicrob Agents Chemother 1999; 43: 2671-7.
31. Tofteland S, Haldorsen B, Dahl KH et al. Effects of phenotype and genotype on methods for detection of extended-spectrum-β-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J Clin Microbiol 2007; 45: 199-205.
32. Lavigne JP, Marchandin H, Delmas J et al. qnrA in CTX-M-producing Escherichia coli isolates from France. Antimicrob Agents Chemother 2006; 50: 4224-8.
33. Lavollay M, Mamlouk K, Frank T et al. Clonal dissemination of a CTX-M-15 β-lactamase-producing Escherichia coli strain in the Paris area, Tunis, and Bangui. Antimicrob Agents Chemother 2006; 50: 2433-8.
34. Naas T, Philippon L, Poirel L et al. An SHV-derived extended-spectrum-β-lactamase in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1999; 43: 1281-4.
35. Leflon-Guibout V, Jurand C, Bonacorsi S et al. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob Agents Chemother 2004; 48: 3736-42.